Preservation of structural integrity of liver lysosomes and membrane-stabilizing action of anti-inflammatory drugs, catecholamines and cyclic adenosine monophosphate in isotonic salt media.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002395:Catecholamines / Q000494:pharmacology*; D002499:Centrifugation, Density Gradient; D003470:Culture Media; D000242:Cyclic AMP / Q000494:pharmacology*; D005696:Galactosidases / Q000378:metabolism; D005966:Glucuronidase / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D006867:Hydrolases / Q000378:metabolism; D066298:In Vitro Techniques; D007552:Isotonic Solutions / Q000494:pharmacology; D008099:Liver / Q000166:cytology*; D008247:Lysosomes / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008566:Membranes / Q000187:drug effects; D011189:Potassium Chloride / Q000494:pharmacology; D011489:Protein Denaturation / Q000187:drug effects; D051381:Rats; D013395:Sucrose; D013431:Sulfates; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D002395:Catecholamines; D003470:Culture Media; D007552:Isotonic Solutions; D013431:Sulfates; D013395:Sucrose; D011189:Potassium Chloride; D006493:Heparin; D000242:Cyclic AMP; D006867:Hydrolases; D000135:Acid Phosphatase; D005696:Galactosidases; D005966:Glucuronidase